| FDA hears concerns on Blood Glucose Meters |
|
On March 16 and 17, 2010, the FDA held a public meeting to discuss concerns about the quality of Blood Glucose Meters. As slides and transcripts have become available of this meeting, Dr. Westgard reviews some of the key points. Please Login (at right) or Register to view article
|
Member Login
What's New
Quality Requirments and Standards
- A Quite Important Quality Indicator
- What's the Right Goal - an example
- Will Molecular Diagnostics repeat our QC mistakes?
- The Quality of Diabetes Testing 2011
- Traceability, Harmonization and Standardization: Why It Matters
- A Dark Secret about the Safety of Medical Devices
- What's the Right Goal?
- Quality of HbA1c, 2011, Part 2
- Quality of HbA1c, 2011
- The Quality Fade
- Quality of Blood Glucose Meters, 2010
- FDA hears concerns on Blood Glucose Meters
- HbA1c in 2010, Part XI
- HbA1c in 2010, Part X
- What's the Q of D? Vitamin D Performance Requirements
- Quality Requirements: The Debate heats up!
- HbA1c for screening and diagnosis of diabetes?
- Need for a System of Quality Standards
- Why Not Evidence-Based Method Specifications?
- Good Data Wanted - Bad Data Should Not Apply (The STARD Initiative)